The tech behind NZ mammogram software firm Volpara’s global success

The tech behind NZ mammogram software firm Volpara’s global success
Around 42% of mammograms in the US touch Volpara software, says CEO Teri Thomas. (Image: Volpara)
Ben Moore
Volpara Health has become a staple name in the medtech industry as a software provider to detect breast cancer in mammogram images.The company was founded in 2009, listed on the Australian securities exchange (ASX) in 2016 and since then has seen strong growth.Chief executive Teri Thomas said 42% of mammograms in the United States touch at least one of Volpara’s products.“We doubled the number of big healthcare organisation engagements in the United States over the last year … from 10 to 20, so we've had record growth and...

More Health

Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

F&P Healthcare: don’t mention the tariffs!
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
Record half for F&P Healthcare
Markets

Record half for F&P Healthcare

A strong result boosts dividend, suspends dividend reinvestment scheme.

Pattrick Smellie 28 Nov 2024
Nanogirl liquidates Lab
Health

Nanogirl liquidates Lab

Nanogirl Labs liquidated as funding cuts hit STEM education.

Garth Bray 28 Nov 2024